TSE:SVA Sernova (SVA) Stock Price, News & Analysis → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free sva Stock Alerts C$0.37 +0.01 (+2.78%) (As of 05/10/2024 08:57 PM ET) Add Compare Share Share Today's RangeC$0.36▼C$0.3850-Day RangeC$0.36▼C$0.6052-Week RangeC$0.36▼C$1.10Volume320,098 shsAverage Volume147,135 shsMarket CapitalizationC$112.26 millionP/E RatioN/ADividend Yield7.86%Price TargetC$1.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlines Get Sernova alerts: Email Address Sernova MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside305.4% UpsideC$1.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.76 out of 5 stars 3.0 Analyst's Opinion Consensus RatingSernova has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageSernova has only been the subject of 1 research reports in the past 90 days.Read more about Sernova's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SVA. Previous Next 1.7 Dividend Strength Dividend LeadershipSernova is a leading dividend payer. It pays a dividend yield of 7.86%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthSernova does not have a long track record of dividend growth.Read more about Sernova's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SVA. Previous Next 0.6 News and Social Media Coverage News SentimentSernova has a news sentiment score of -0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Sernova this week, compared to 0 articles on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sernova insiders have not sold or bought any company stock.Percentage Held by Insiders12.71% of the stock of Sernova is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.05% of the stock of Sernova is held by institutions.Read more about Sernova's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sernova is -2.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sernova is -2.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSernova has a P/B Ratio of 37.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Sernova's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. About Sernova Stock (TSE:SVA)Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.Read More SVA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SVA Stock News HeadlinesMay 3, 2024 | americanbankingnews.comSernova (TSE:SVA) Shares Down 5.8% April 25, 2024 | finance.yahoo.comSernova Provides Organizational UpdateMay 13, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.April 2, 2024 | theglobeandmail.comSernova Provides Positive Clinical and Platform Portfolio UpdateMarch 14, 2024 | theglobeandmail.comNYC Arts Organization, Autumn Salon, Announces Next Concert 'Music Box'February 20, 2024 | finance.yahoo.comSernova Corp (PSH.MU)February 17, 2024 | morningstar.comSernova Corp SVAJanuary 9, 2024 | finance.yahoo.comWe Think Sernova (TSE:SVA) Can Afford To Drive Business GrowthMay 13, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.November 27, 2023 | markets.businessinsider.comSernova Gets FDA Orphan Drug, Rare Pediatric Disease Designations For Hemophilia A ProgramNovember 27, 2023 | finance.yahoo.comSernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDAOctober 11, 2023 | finance.yahoo.comSernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA CongressOctober 4, 2023 | markets.businessinsider.comH.C. Wainwright Thinks Sernova’s Stock is Going to RecoverSeptember 29, 2023 | markets.businessinsider.comH.C. Wainwright Reaffirms Their Buy Rating on Sernova (SVA)September 14, 2023 | markets.businessinsider.comSernova (SVA) Gets a Buy Rating from Echelon Wealth PartnersSeptember 14, 2023 | finance.yahoo.comSernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22September 13, 2023 | finance.yahoo.comSernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business UpdateSeptember 5, 2023 | markets.businessinsider.comEchelon Wealth Partners Maintains Their Buy Rating on Sernova (SVA)August 4, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Wednesday (SVA)August 2, 2023 | finance.yahoo.comIs Sernova (TSE:SVA) In A Good Position To Invest In Growth?July 26, 2023 | finance.yahoo.comSernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business OfficerMay 3, 2023 | marketwatch.comEQS-News: Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell ApplicationsMay 3, 2023 | finance.yahoo.comSernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell ApplicationsApril 29, 2023 | theglobeandmail.comClosing Bell: Sernova Corp up on Friday (SVA)April 21, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Friday (SVA)April 19, 2023 | theglobeandmail.comClosing Bell: Sernova Corp down on Tuesday (SVA)April 18, 2023 | theglobeandmail.comClosing Bell: Sernova Corp up on Monday (SVA)See More Headlines Receive SVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/18/2024Today5/12/2024Next Earnings (Estimated)6/11/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:SVA CUSIPN/A CIKN/A Webwww.sinovacbio.com Phone861082890088FaxN/AEmployees1,959Year FoundedN/APrice Target and Rating Average Stock Price TargetC$1.50 High Stock Price TargetC$1.50 Low Stock Price TargetC$1.50 Potential Upside/Downside+305.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-40,730,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-183.58% Return on Assets-79.96% Debt Debt-to-Equity Ratio16.55 Current Ratio1.20 Quick Ratio18.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.06 per share Price / Cash Flow6.15 Book ValueC$0.01 per share Price / Book37.00Miscellaneous Outstanding Shares303,410,000Free FloatN/AMarket CapC$112.26 million OptionableNot Optionable Beta1.48 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. Philip M. Toleikis B.A.M.Sc., Ph.D., President, CTO, Director of Technology & DirectorMr. Christopher BarnesVice President of Investor RelationsDr. Frank Shannon M.D.Vice President of Clinical Development & Regulatory AffairsMs. Cynthia PussinenCEO & DirectorMr. Nicholas J. Rossettos CPA (Age 58)M.B.A., Interim Chief Financial Officer Mr. Douglas MaretChief Science OfficerDr. Modestus Obochi M.B.A.Ph.D., Chief Business OfficerMore ExecutivesKey CompetitorsOncolytics BiotechTSE:ONCScythian BiosciencesCVE:SCYB138267 (COM.TO)TSE:COMNovoheartCVE:NVHIntelGenx TechnologiesCVE:IGXView All Competitors SVA Stock Analysis - Frequently Asked Questions Should I buy or sell Sernova stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sernova in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SVA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SVA, but not buy additional shares or sell existing shares. View SVA analyst ratings or view top-rated stocks. What is Sernova's stock price target for 2024? 1 Wall Street analysts have issued twelve-month price targets for Sernova's stock. Their SVA share price targets range from C$1.50 to C$1.50. On average, they expect the company's share price to reach C$1.50 in the next twelve months. This suggests a possible upside of 305.4% from the stock's current price. View analysts price targets for SVA or view top-rated stocks among Wall Street analysts. How have SVA shares performed in 2024? Sernova's stock was trading at C$0.70 at the beginning of the year. Since then, SVA shares have decreased by 47.1% and is now trading at C$0.37. View the best growth stocks for 2024 here. When is Sernova's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 11th 2024. View our SVA earnings forecast. How were Sernova's earnings last quarter? Sernova Corp. (TSE:SVA) announced its quarterly earnings results on Monday, March, 18th. The company reported ($0.03) EPS for the quarter, meeting analysts' consensus estimates of ($0.03). How do I buy shares of Sernova? Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:SVA) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.